Stock Splits
By The Online Investor Staff, updated Mon., Jul. 22, 7:52 AM
| This Slide: #9 of 25 |
Slide #9. Jaguar Health, Inc. (NASDAQ:JAGX) — 1 for 70 Reverse Split
Announced:
6/6/2019
Stock Split:
1 for 70
Record Date:
6/6/2019
Pay Date:
6/7/2019
JAGX Optionable?:
No
Jaguar Health is a commercial stage natural-products pharmaceuticals company focused on developing gastrointestinal products for both human prescription use and animals. Co.'s Mytesi (crofelemer) product is approved by the U.S. Food and Drug Administration for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Co. also focuses on developing and commercializing gastrointestinal products for companion and production animals, foals, and horses including Neonorm Foal, which is an antidiarrheal product for newborn horses and Neonorm Calf, which is an antidiarrheal product for preweaned dairy calves. 
JAGX Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the JAGX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Buy (3.00 out of 4) 37th percentile
(ranked lower than approx. 63% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
